MultiCell Technologies, Inc. is a clinical stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease, fatigue of MS and cancer. The majority owned Xenogenics subsidiary is developing a drug eluting cardiac stent.
Quote | Multicell Techs Inc (OTCMKTS:MCET)
Last: | $1e-06 |
---|---|
Change Percent: | -49900.0% |
Open: | $0.0005 |
Close: | $1e-06 |
High: | $0.0005 |
Low: | $1e-06 |
Volume: | 8,502,000 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Multicell Techs Inc (OTCMKTS:MCET)
Message Board Posts | Multicell Techs Inc (OTCMKTS:MCET)
Subject | By | Source | When |
---|---|---|---|
VOLUME | Sea Monkey | investorshub | 04/28/2023 8:00:55 PM |
Look into the arrangement $MCET/Dr.Faris has with Corning. | galingolin | investorshub | 03/09/2023 6:24:09 PM |
for starter check this link: | galingolin | investorshub | 03/09/2023 6:14:56 PM |
That does it! I will buy $MCET for | Fiberman | investorshub | 03/07/2023 8:54:39 PM |
I find this interesting, can you give us | bojangles88 | investorshub | 03/07/2023 1:09:33 PM |